Genome‐wide gain‐of‐function screening identifies EZH2 mediating resistance to PI3Kα inhibitors in oesophageal squamous cell carcinoma

Phosphoinositide‐3 kinase alpha (PI3Kα) has been confirmed to be a potential therapeutic target for esophageal squamous cell carcinoma (ESCC), while the potency of PI3Kα inhibitors is often attenuated by concurrent oncogenic signalling pathways. We performed genome‐wide gain‐of‐function screening wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Hui, Gao, Mengshi, Wang, Yuxiang, Zhang, Xu, Shi, Jiajie, Wang, Xiang, Liu, Xueling, Ma, Qingyang, Kong, Xiangyin, Yang, Chunhao, Ding, Jian, Meng, Linghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126361/
https://www.ncbi.nlm.nih.gov/pubmed/35604910
http://dx.doi.org/10.1002/ctm2.835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126361/
https://www.ncbi.nlm.nih.gov/pubmed/35604910
http://dx.doi.org/10.1002/ctm2.835

Ejemplares similares